A German Chlamydia trachomatis screening program employing semi-automated real-time PCR: results and perspectives

Journal of Clinical Virology

Volumn 46, Issue SUPPL. 3, 2009, Pages

  Bohm I ^a   Groning A ^a   Sommer, B ^a   Muller H W ^a   Krawczak, M ^b   Glaubitz, R ^c  

^a MVZ Wagner Stibbe für Laboratoriumsmedizin Gynäkologie Humangenetik und Pathologie GmbH   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Ruhr GmbH   (Germany)

Author keywords

Chlamydia trachomatis; Pooling; Public health; Real time PCR; Screening

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENOME; GERMANY; GROUPS BY AGE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALIDITY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; SENSITIVITY ANALYSIS; URINALYSIS; UTERINE CERVIX CYTOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AUTOMATION, LABORATORY; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DNA, BACTERIAL; FEMALE; GERMANY; HUMANS; LIMIT OF DETECTION; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VAGINAL SMEARS;

EID: 72549117830     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(09)70298-7     Document Type: Article

References (31)

1. World Health Organisation. Global prevalence and incidence of selected curable sexually transmitted infections: Chlamydia estimates 2001. 02. http://www.who.int/docstore/hiv/GRSTI/who_hiv_aids_2001.02.pdf
2. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2005 supplement, Chlamydia Prevalence Monitoring Project Annual Report 2005. Division of STD Prevention December 2006. Department of Health and Human Services. Atlanta, GA: CDC.
3. WHO Regional Office for Europe. Technical briefing document 01B/06; Trends in sexually transmitted infections and HIV in the European Region, 1980-2005. Copenhagen, 12 September 2006. http://www.euro.who.int/Document/RC56/etb01b.pdf
4. Wilson J.S., Honey E., Templeton A., Paavonen J., Mardh P.A., Stary A., et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 8 (2002) 385-394
5. Pimenta J.M., Catchpole M., Rogers P.A., Hopwood J., Randall S., Mallinson H., et al. Opportunistic screening for genital chlamydial infection. II: Prevalence among healthcare attenders, outcome, and evaluation of positive cases. Sex Transm Infect 79 (2003) 22-27
6. Macleod J., Salisbury C.H., Nicola Low N., McCarthy A., Sterne J., Holloway A., et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 330 (2005) 940 10.1136/bmj.38413.663137.8F
7. Watson E.J., Templeton A., Russell I., Paavonen J., Mardh P.A., Stary A., et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 51 (2002) 1021-1031
8. Schachter J., McCormack W.M., Chernesky M.A., Martin D.H., Van Der Pol B., Rice P.A., et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 41 (2003) 3784-3789
9. Skidmore S., Horner P., Herring A., Sell J., Paul I., Thomas J., et al. Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?. J Clin Microbiol 44 (2006) 4389-4394
10. Schachter J., Chernesky M.A., Willis D.E., Fine P.M., Martin D.H., Fuller D., et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 32 (2005) 725-728
11. Currie M.J., McNiven M., Yee T., Schiemer U., and Francis J.B. Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving. J Clin Microbiol 42 (2004) 4866-4867
12. Rours G.I., Verkooyen R.P., Willemse H.F., van der Zwaan E.A., van Belkum A., de Groot R., et al. Use of pooled urine samples and automated DNA isolation to achieve improved sensitivity and cost-effectiveness of large-scale testing for Chlamydia trachomatis in pregnant women. J Clin Microbiol 43 (2005) 4684-4690
13. Low N. Screening programmes for chlamydial infection: when will we ever learn?. BMJ 334 (2007) 725-728
14. Ripa T., and Nilsson P. Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. Sex Transm Dis 34 (2007) 255-256
15. Mahony J., Chong S., Jang D., Luinstra K., Faught M., Dalby D., et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 36 (1998) 3122-3126
16. Livengood III C.H., and Wrenn J.W. Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens. J Clin Microbiol 39 (2001) 2928-2932
17. van Doornum G.J., Schouls L.M., Pijl A., Cairo I., Buimer M., and Bruisten S. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol 39 (2001) 829-835
18. Levett P.N., Brandt K., Olenius K., Brown C., Montgomery K., and Horsman G.B. Evaluation of three automated nucleic acid amplification systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens. J Clin Microbiol 46 (2008) 2109-2111
19. Michel C.E., Sonnex C., Carne C.A., White J.A., Magbanua J.P., Nadala Jr. E.C., et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 45 (2007) 1395-1402
20. Adams E.J., Charlett A., Edmunds W.J., and Hughes G. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect 80 (2004) 354-362
21. Burstein G.R., Zenilman J.M., Gaydos C.A., Diener-West M., Howell M.R., Brathwaite W., et al. Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect 77 (2001) 26-32
22. Datta S.D., Sternberg M., Johnson R.E., Berman S., Papp J.R., McQuillan G., et al. Gonorrhea and Chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 147 (2007) 89-96
23. van Bergen J., Gotz H.M., Richardus J.H., Hoebe C.J., Broer J., Coenen A.J., et al. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 81 (2005) 17-23
24. Goessens W.H.F., Mouton J.W., van der Meijden W.I., Deelen S., Van Rijsoort-Vos T.H., Lemmens-Den Toom N., et al. Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine. J Clin Microbiol 35 (1997) 2628-2633
25. McMillan H.M., O'Carroll H., Lambert J.S., Grundy K.B., O'Reilly M., Lennon B., et al. Screening for Chlamydia trachomatis in asymptomatic women attending outpatient clinics in a large maternity hospital in Dublin, Ireland. Sex Transm Infect 82 (2006) 503-505
26. Johnson C.C., Jones E.H., Goldberg M., Asbel L.E., Salmon M.E., and Waller C.L. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among adolescents in Family Court, Philadelphia, Pennsylvania. Sex Transm Dis 35 11 Suppl (2008) S24-S27
27. Johnson H.L., Erbelding E.J., Zenilman J.M., and Ghanem K.G. Sexually transmitted diseases and risk behaviors among pregnant women attending inner city public sexually transmitted diseases clinics in Baltimore, MD, 1996-2002. Sex Transm Dis 34 (2007) 991-994
28. Clad A., Prillwitz J., Hintz K.C., Mendel R., Flecken U., Schulte-Mönting J., et al. Discordant prevalence of Chlamydia trachomatis in asymptomatic couples screened using urine ligase chain reaction. Eur J Clin Microbiol Infect Dis 20 (2001) 324-328
29. Griesinger G., Gille G., Klapp C., von Otte S., and Diedrich K. Sexual behaviour and Chlamydia trachomatis infections in German female urban adolescents, 2004. Clin Microbiol Infect 13 (2007) 436-439
30. Eggert-Kruse W., Rohr G., Kunt B., Meyer A., Wondra J., Strowitzki T., et al. Prevalence of Chlamydia trachomatis in subfertile couples. Fertil Steril 80 (2003) 660-663
31. Clad A., and Meyer T. Chlamydien - haeufigste Sterilitaetsursache der Frau. Gynaekologe 40 (2007) 207-217